- In October 2024, CMR Surgical announced that it has obtained Food and Drug Administration (FDA) approval for its Versius robotic system, with the initial indication for gallbladder removal surgery. As part of a multi-phase strategic plan, CMR will collaborate with select hospitals to introduce the robot in the United States.
- In June 2024, B. Braun Interventional Systems Inc. (BIS) introduced its new ACCEL All-Purpose and Biliary Drainage Catheters, featuring TrueGlide Hydrophilic Coating for percutaneous drainage. These catheters are designed to enhance both patient comfort and clinical performance. The ACCEL catheters feature large oval holes to optimize fluid drainage capacity, while the TrueGlide Hydrophilic Coating ensures smooth and easy catheter insertion.
- In April 2024, Dornier MedTech unveiled UroGPT, an Artificial Intelligence (AI) tool aimed at assisting kidney stone patients. This launch represents a significant step in the company’s commitment to utilizing digital innovation to offer patient-centric healthcare solutions. UroGPT showcases Dornier MedTech's focus on leveraging cutting-edge digital health technologies to enhance patient care and engagement. The tool offers urology patients on-demand guidance and valuable insights, helping them navigate the challenges of their condition with informed reassurance.
- In October 2023, Levita Magnetics announced the world’s first commercial use of its MARS platform. MARS, an innovative surgical system utilizing Levita’s proprietary Dynamic Magnetic Positioning technology, recently received FDA clearance for high-volume abdominal surgeries. This includes procedures such as laparoscopic bariatric surgery, cholecystectomy (gallbladder removal), as well as prostate and colorectal surgeries.
- In February 2023, Olympus Corporation announced its agreement to acquire Taewoong Medical Co., Ltd., a Korea-based manufacturer of medical devices, including gastrointestinal (GI) metallic stents. Metallic stents are commonly used to treat jaundice, a symptom of a blocked or narrowed biliary tract, often caused by biliary cancer.
